1. Home
  2. AXR vs MOLN Comparison

AXR vs MOLN Comparison

Compare AXR & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXR
  • MOLN
  • Stock Information
  • Founded
  • AXR 1961
  • MOLN 2004
  • Country
  • AXR United States
  • MOLN Switzerland
  • Employees
  • AXR N/A
  • MOLN N/A
  • Industry
  • AXR Homebuilding
  • MOLN
  • Sector
  • AXR Real Estate
  • MOLN
  • Exchange
  • AXR Nasdaq
  • MOLN Nasdaq
  • Market Cap
  • AXR 157.3M
  • MOLN 183.2M
  • IPO Year
  • AXR N/A
  • MOLN 2021
  • Fundamental
  • Price
  • AXR $27.18
  • MOLN $4.68
  • Analyst Decision
  • AXR
  • MOLN
  • Analyst Count
  • AXR 0
  • MOLN 0
  • Target Price
  • AXR N/A
  • MOLN N/A
  • AVG Volume (30 Days)
  • AXR 12.2K
  • MOLN 2.1K
  • Earning Date
  • AXR 03-07-2025
  • MOLN 03-13-2025
  • Dividend Yield
  • AXR N/A
  • MOLN N/A
  • EPS Growth
  • AXR N/A
  • MOLN N/A
  • EPS
  • AXR 2.30
  • MOLN N/A
  • Revenue
  • AXR $63,223,000.00
  • MOLN $7,105,397.00
  • Revenue This Year
  • AXR N/A
  • MOLN N/A
  • Revenue Next Year
  • AXR N/A
  • MOLN N/A
  • P/E Ratio
  • AXR $11.82
  • MOLN N/A
  • Revenue Growth
  • AXR 54.34
  • MOLN N/A
  • 52 Week Low
  • AXR $15.88
  • MOLN $3.32
  • 52 Week High
  • AXR $39.67
  • MOLN $12.70
  • Technical
  • Relative Strength Index (RSI)
  • AXR 30.72
  • MOLN 35.14
  • Support Level
  • AXR $29.54
  • MOLN $4.78
  • Resistance Level
  • AXR $30.83
  • MOLN $4.96
  • Average True Range (ATR)
  • AXR 0.84
  • MOLN 0.08
  • MACD
  • AXR -0.28
  • MOLN -0.02
  • Stochastic Oscillator
  • AXR 0.00
  • MOLN 0.00

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve the obtaining of approvals and the sale of both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: